Загрузка...
Aflibercept Versus Bevacizumab and/or Ranibizumab for Recurrent Macular Edema Secondary to Central Retinal Vein Occlusion
Purpose: To compare functional and anatomic outcomes of treatment with intravitreal aflibercept versus bevacizumab and/or ranibizumab in patients with recurrent macular edema (ME) secondary to central retinal vein occlusion (CRVO). Methods: Retrospective, comparative case series of patients with rec...
Сохранить в:
| Опубликовано в: : | J Ocul Pharmacol Ther |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Mary Ann Liebert, Inc.
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5952344/ https://ncbi.nlm.nih.gov/pubmed/29447089 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/jop.2017.0074 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|